Qualigen Therapeutics, Inc. — Director's Dealing 2016

Feb 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2016-02-22

Reporting Person: Ritter Andrew J (Director, President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-22	Common Stock	P	6250	$1.60	Acquired	6250	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	817272	Indirect

Footnotes

F1: As a managing partner of Stonehenge Partners LLC, the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.